{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:17:18Z","timestamp":1792221438271,"version":"4.4.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1998,4,1]],"date-time":"1998-04-01T00:00:00Z","timestamp":891388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1998,4,1]],"date-time":"1998-04-01T00:00:00Z","timestamp":891388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology and Immunopathology"],"published-print":{"date-parts":[[1998,4]]},"DOI":"10.1006\/clin.1997.4501","type":"journal-article","created":{"date-parts":[[2002,10,6]],"date-time":"2002-10-06T20:18:03Z","timestamp":1033935483000},"page":"42-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Selective Response of CD5+B Cell Malignancies to Activation of the CD72 Antigen"],"prefix":"10.1006","volume":"87","author":[{"given":"E.V.","family":"Planken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Van de Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.H.F.","family":"Falkenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Thielemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Willemze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Kluin-Nelemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1006\/clin.1997.4501_II974501RF1","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/351662a0","article-title":"The B-cell surface protein CD72\/Lyb-2 is the ligand for CD5","volume":"351","author":"Van de Velde","year":"1991","journal-title":"Nature"},{"key":"10.1006\/clin.1997.4501_II974501RF2","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.4049\/jimmunol.148.6.1630","article-title":"Ly-1 (CD5), a membrane glycoprotein of mouse T lymphocytes and a subset of B cells, is a natural ligand of the B cell surface protein Lyb-2 (CD72)","volume":"148","author":"Luo","year":"1992","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4501_II974501RF3","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1084\/jem.184.3.811","article-title":"Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes","volume":"184","author":"Biancone","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4501_II974501RF4","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1084\/jem.155.2.623","article-title":"Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia","volume":"155","author":"Caligaris-Cappio","year":"1982","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4501_II974501RF5","first-page":"98","article-title":"A novel human T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas","volume":"127","author":"Kamoen","year":"1981","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4501_II974501RF6","first-page":"1557","article-title":"Leukemia-associated changes identified by quantitative flow cytometry. II. CD5 over-expression and monitoring in B-CLL","volume":"8","author":"Lavabre-Bertrand","year":"1994","journal-title":"Leukemia"},{"key":"10.1006\/clin.1997.4501_II974501RF7","series-title":"Leucocyte Typing IV. White Cell Differentiation Antigens","article-title":"B-cell antigens: CD72","author":"D\u00f6rken","year":"1989"},{"key":"10.1006\/clin.1997.4501_II974501RF8","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.4049\/jimmunol.130.5.2033","article-title":"Induction of B lymphocyte proliferation by monoclonal anti-lyb 2 antibody","volume":"130","author":"Subbarao","year":"1983","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4501_II974501RF9","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/eji.1830210614","article-title":"Stimulation of B lymphocytes via CD72 (human Lyb-2)","volume":"21","author":"Kamal","year":"1991","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clin.1997.4501_II974501RF10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/cimm.1996.0218","article-title":"Native soluble CD5 delivers a co-stimulatory signal to resting human B lymphocytes","volume":"172","author":"Van de Velde","year":"1996","journal-title":"Cell. Immunol."},{"key":"10.1006\/clin.1997.4501_II974501RF11","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.4049\/jimmunol.137.6.1793","article-title":"Enhancement by monoclonal anti-lyb-2 antibody of antigen-specific B lymphocyte expansion stimulated by TNP-ficoll and T lymphocyte-derived factors","volume":"137","author":"Snow","year":"1986","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4501_II974501RF12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0167-5699(93)90063-Q","article-title":"B-cell lineages exist in the mouse","volume":"14","author":"Herzenberg","year":"1993","journal-title":"Immunol. Today"},{"key":"10.1006\/clin.1997.4501_II974501RF13","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/0167-5699(91)90135-G","article-title":"The development and repertoire of B-1 cells (CD5 B cells)","volume":"12","author":"Kantor","year":"1991","journal-title":"Immunol. Today"},{"key":"10.1006\/clin.1997.4501_II974501RF14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0065-2776(08)60663-X","article-title":"The CD5+B cell","volume":"47","author":"Kipps","year":"1989","journal-title":"Adv. Immunol."},{"key":"10.1006\/clin.1997.4501_II974501RF15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1749-6632.1992.tb24622.x","article-title":"Multiple IL-10 antibody treatment blocks the development of Ly-1 lineage B cells","volume":"651","author":"Ishida","year":"1992","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1006\/clin.1997.4501_II974501RF16","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/blood.V70.2.418.418","article-title":"Normal cellular counterparts of B cell chronic lymphocytic leukemia","volume":"70","author":"Freedman","year":"1987","journal-title":"Blood"},{"key":"10.1006\/clin.1997.4501_II974501RF17","first-page":"601","article-title":"The nature of the B lymphocyte in B-chronic lymphocytic leukemia","volume":"19","author":"Caligaris-Cappio","year":"1993","journal-title":"Blood Cells"},{"key":"10.1006\/clin.1997.4501_II974501RF18","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1182\/blood.V79.11.2981.2981","article-title":"Growth- and differentiation-associated expression ofbcl-2 in B-chronic lymphocytic leukemia cells","volume":"79","author":"Schena","year":"1992","journal-title":"Blood"},{"key":"10.1006\/clin.1997.4501_II974501RF19","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1093\/intimm\/8.6.867","article-title":"Antigen receptor-mediated B cell death is blocked by signaling via CD72 or treatment with dextran sulfate and is defective in autoimmunity-prone mice","volume":"8","author":"Nomura","year":"1996","journal-title":"Int. Immunol."},{"key":"10.1006\/clin.1997.4501_II974501RF20","unstructured":"Chang, J. F. Parnes, J. R. The role of CD72 in B cell maturation: B cell receptor (BCR)-induced apoptosis in immature B cells is blocked by CD72 signalling, J. Cell. Biochem. 66, C2, 112"},{"key":"10.1006\/clin.1997.4501_II974501RF21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/intimm\/7.2.305","article-title":"Involvement of CD5 in TH1 and TH2 contact dependent rescue of anti-\u03bc and ionomycin induced growth inhibition in a B cell lymphoma","volume":"7","author":"Subramanian","year":"1995","journal-title":"Int. Immunol."},{"key":"10.1006\/clin.1997.4501_II974501RF22","first-page":"319a","article-title":"CD5+malignant B cells can be activated via the CD72 antigen","volume":"86","author":"Planken","year":"1995","journal-title":"Blood"},{"key":"10.1006\/clin.1997.4501_II974501RF23","first-page":"40","article-title":"In vitroactivation of leukaemic B cells by interleukin-4 and antibodies to CD40","volume":"80","author":"Crawford","year":"1993","journal-title":"Immunology"},{"key":"10.1006\/clin.1997.4501_II974501RF24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3109\/10428199109103373","article-title":"In vitroactivation of B-CLL cells","volume":"5","author":"Defrance","year":"1991","journal-title":"Leuk. Lymphoma"},{"key":"10.1006\/clin.1997.4501_II974501RF25","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood.V80.12.3173.3173","article-title":"Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors","volume":"80","author":"Fluckiger","year":"1992","journal-title":"Blood"},{"key":"10.1006\/clin.1997.4501_II974501RF26","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.4049\/jimmunol.144.12.4870","article-title":"Identification of a human protein homologous to the mouse Lyb-2 B cell differentiation antigen and sequence of the corresponding cDNA","volume":"144","author":"von Hoegen","year":"1990","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4501_II974501RF27","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1002\/eji.1830210615","article-title":"Identity of human Lyb-2 and CD72 and localization of the gene to chromosome 9","volume":"21","author":"von Hoegen","year":"1991","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clin.1997.4501_II974501RF28","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/353678a0","article-title":"Growing human B lymphocytes in the CD40 system","volume":"353","author":"Banchereau","year":"1991","journal-title":"Nature"},{"key":"10.1006\/clin.1997.4501_II974501RF29","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1084\/jem.184.4.1279","article-title":"CD5 is a potential selecting ligand for B cell surface immunoglobulin framework region sequences","volume":"184","author":"Pospisil","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1006\/clin.1997.4501_II974501RF30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/cimm.1996.1033","article-title":"CD72 ligation regulates defective naive newborn B cell responses","volume":"175","author":"Howard","year":"1997","journal-title":"Cell. Immunol."},{"key":"10.1006\/clin.1997.4501_II974501RF31","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/eji.1830240406","article-title":"CD5 is associated with the human B cell antigen receptor complex","volume":"24","author":"Lankester","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clin.1997.4501_II974501RF32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2249.1992.tb06936.x","article-title":"Il-4 down-regulates the surface expression of CD5 on B cells and inhibits spontaneous immunoglobulin and IgM-rheumatoid factor production in patients with rheumatoid arthritis","volume":"89","author":"Hidaka","year":"1992","journal-title":"Clin. Exp. Immunol."},{"key":"10.1006\/clin.1997.4501_II974501RF33","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/eji.1830190709","article-title":"Cell surface antigen CD5 is a marker for activated human B cells","volume":"19","author":"Werner-Favre","year":"1989","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clin.1997.4501_II974501RF34","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.4049\/jimmunol.157.5.1854","article-title":"The CD5\/CD72 receptor system is coexpressed with several functionally relevant counterstructures on human B cells and delivers a critical signaling activity","volume":"157","author":"Cerutti","year":"1996","journal-title":"J. Immunol."},{"key":"10.1006\/clin.1997.4501_II974501RF35","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/eji.1830190818","article-title":"Activation of human B lymphocytes through CD40 and interleukin 4","volume":"19","author":"Vall\u00e9","year":"1989","journal-title":"Eur. J. Immunol."},{"key":"10.1006\/clin.1997.4501_II974501RF36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0145-2126(94)90009-4","article-title":"Interleukin-4 (IL-4) inhibits proliferation and spontaneous cytokine release by chronic lymphocytic leukaemia cells","volume":"18","author":"Reittie","year":"1994","journal-title":"Leuk. Res."},{"key":"10.1006\/clin.1997.4501_II974501RF37","first-page":"1583","article-title":"Low-grade B cell lymphomas of mucosa-associated lymphoikd tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines forin vitrogrowth and differentiation","volume":"150","author":"Greiner","year":"1997","journal-title":"Am. J. Pathol."}],"container-title":["Clinical Immunology and Immunopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090122997945013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090122997945013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T01:09:21Z","timestamp":1758762561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090122997945013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,4]]}},"alternative-id":["S0090122997945013"],"URL":"https:\/\/doi.org\/10.1006\/clin.1997.4501","relation":{},"ISSN":["0090-1229"],"issn-type":[{"value":"0090-1229","type":"print"}],"subject":[],"published":{"date-parts":[[1998,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective Response of CD5+B Cell Malignancies to Activation of the CD72 Antigen","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology and Immunopathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1006\/clin.1997.4501","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1998 Academic Press. All rights reserved.","name":"copyright","label":"Copyright"}]}}